The provision of Artificial Intelligence Clinical trial matching software

Description

Velindre University NHS Trust require an Artificial Intelligence (AI) software Clinical Trials Matching Products in reading structured and un-structured data in patient records for the purpose of matching patient for inclusion/exclusion to/from clinical trials. This will enable Velindre University NHS Trust to improve its participation in clinical trials with the aim of providing an improved outcome for patients along with aligning ourselves with the Trusts AI strategy. It is key for the Trust to have a solution that provides AI capability to deliver its’ obligations of matching patients to the most suitable clinical trial. Therefore the Trust is proposing to directly award a contract to IBM UK Ltd. Please note that this is a Ex Voluntary Transparency Notice to inform the market of our intention for 10 calendar days. Velindre University NHS Trust (OJEU Reference 2019/S 042-094659) held supplier engagement day to establish market readiness of Artificial Intelligence (AI) software Clinical Trials Matching Products in reading structured and un-structured data in patient records for the purpose of matching patient for inclusion/exclusion to/from clinical trials. The supplier day identified that only one supplier currently has a fully developed off-the shelf AI solution (Watson Clinical Trials Matching) that will enable Velindre University NHST Trust to improve its participation in clinical trials with the aim of providing an improved outcome for patients along with aligning ourselves with the Trusts AI strategy. It is key for the Trust to have a solution that provides AI capability to deliver its’ obligations of matching patients to the most suitable clinical trial. Therefore the Trust is proposing to directly award a contract to IBM UK Ltd for the provision of an AI Clinical Trials Matching system by placing reliance upon Regulation 32 (2) (b) (ii) (competition absent for technical reasons) Following the issue of the PIN notice and market engagement IBM UK Ltd are the only supplier able to deliver the software solution within the required timescales ( and the Intellectual Property vests wholly in them - client to delete is not relying upon exclusive rights ground). It is proposed that the contract duration shall be for an initial 15 months period with options to extend up to a further 12 months. Please note that this is a Ex Voluntary Transparency Notice to inform the market of our intention for 10 calendar days. Lot 1: Velindre University NHS Trust (OJEU Reference 2019/S 042-094659) held supplier engagement day to establish market readiness of Artificial Intelligence (AI) software Clinical Trials Matching Products in reading structured and un-structured data in patient records for the purpose of matching patient for inclusion/exclusion to/from clinical trials. The supplier day identified that only one supplier currently has a fully developed off-the shelf AI solution (Watson Clinical Trials Matching) that will enable Velindre University NHST Trust to improve its participation in clinical trials with the aim of providing an improved outcome for patients along with aligning ourselves with the Trusts AI strategy. It is key for the Trust to have a solution that provides AI capability to deliver its’ obligations of matching patients to the most suitable clinical trial. Therefore the Trust is proposing to directly award a contract to IBM UK Ltd for the provision of an AI Clinical Trials Matching system by placing reliance upon Regulation 32 (2) (b) (ii) (competition absent for technical reasons) Following the issue of the PIN notice and market engagement IBM UK Ltd are the only supplier able to deliver the software solution within the required timescales ( and the Intellectual Property vests wholly in them - client to delete is not relying upon exclusive rights ground). It is proposed that the contract duration shall be for an initial 15 months period with options to extend up to a further 12 months. Please note that this is a Ex Voluntary Transparency Notice to inform the market of our intention for 10 calendar days.